ViaDerma, Inc.
VDRM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $12 | $6 | $9 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $13 | $6 | $9 | $2 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 11.1% | 5.2% | 4,382.1% | – |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 100% | 100% | 99.5% | 94.4% |
| EBITDA | $0 | $1 | -$1 | -$0 |
| % Margin | 13.4% | 127.6% | -171.8% | -2,464.3% |
| Net Income | $0 | $1 | -$1 | -$0 |
| % Margin | 0.7% | 109.3% | -193.4% | -3,764.2% |
| EPS Diluted | 0 | 0.001 | -0.001 | -0.001 |
| % Growth | -100% | 160% | -66.7% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |